- call +1-201-465-4211
- email sales@marketsandresearch.biz
- Call +1-201-465-4211
- Email: sales@marketsandresearch.biz
According to our latest study, the global Saliva-based Screening market size was valued at USD million in 2022 and is forecast to a readjusted size of USD million by 2029 with a CAGR of % during review period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
This report is a detailed and comprehensive analysis for global Saliva-based Screening market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2023, are provided.
Key Features:
Global Saliva-based Screening market size and forecasts, in consumption value ($ Million), 2018-2029
Global Saliva-based Screening market size and forecasts by region and country, in consumption value ($ Million), 2018-2029
Global Saliva-based Screening market size and forecasts, by Type and by Application, in consumption value ($ Million), 2018-2029
Global Saliva-based Screening market shares of main players, in revenue ($ Million), 2018-2023
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Saliva-based Screening
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Saliva-based Screening market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Thermo Fisher scientific, Qiagen, Hologic, Takara Bio Inc and Arcis Biotechnology Limited, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Market segmentation
Saliva-based Screening market is split by Type and by Application. For the period 2018-2029, the growth among segments provide accurate calculations and forecasts for consumption value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Direct Sample to PCR
RT-qPCR
Lateral Flow Assays
Market segment by Application
Diagnostic Laboratories
Hospitals & Clinics
Others
Market segment by players, this report covers
Thermo Fisher scientific
Qiagen
Hologic
Takara Bio Inc
Arcis Biotechnology Limited
GeneProof
Abacus ALS
Chai Inc.
Kolplast Group
Lucence Health INc
Vitagene
Therma Bright Inc
ACON Laboratories, Inc
TODA PHARMA
Norgen Biotek Corp.
Assure Tech. (Hangzhou) Co., Ltd
Beijing Hotgen Biotech Co., Ltd
Nantong Diagnos Biotechnology Co., Ltd
NeuMoDx Molecular, Inc.
KYODO INTERNATIONAL INC.
Canvax
Zymo Research Corporation.
Salimetrics
NEST Scientific USA
Miraclean Technology Co. Ltd
Mawi DNA Technologies
Cell Projects Ltd.
Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia and Rest of Asia-Pacific)
South America (Brazil, Argentina and Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 13 chapters:
Chapter 1, to describe Saliva-based Screening product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Saliva-based Screening, with revenue, gross margin and global market share of Saliva-based Screening from 2018 to 2023.
Chapter 3, the Saliva-based Screening competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with consumption value and growth rate by Type, application, from 2018 to 2029.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2018 to 2023.and Saliva-based Screening market forecast, by regions, type and application, with consumption value, from 2024 to 2029.
Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War
Chapter 12, the key raw materials and key suppliers, and industry chain of Saliva-based Screening.
Chapter 13, to describe Saliva-based Screening research findings and conclusion.
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
1 Market Overview
1.1 Product Overview and Scope of Saliva-based Screening
1.2 Market Estimation Caveats and Base Year
1.3 Classification of Saliva-based Screening by Type
1.3.1 Overview: Global Saliva-based Screening Market Size by Type: 2018 Versus 2022 Versus 2029
1.3.2 Global Saliva-based Screening Consumption Value Market Share by Type in 2022
1.3.3 Direct Sample to PCR
1.3.4 RT-qPCR
1.3.5 Lateral Flow Assays
1.4 Global Saliva-based Screening Market by Application
1.4.1 Overview: Global Saliva-based Screening Market Size by Application: 2018 Versus 2022 Versus 2029
1.4.2 Diagnostic Laboratories
1.4.3 Hospitals & Clinics
1.4.4 Others
1.5 Global Saliva-based Screening Market Size & Forecast
1.6 Global Saliva-based Screening Market Size and Forecast by Region
1.6.1 Global Saliva-based Screening Market Size by Region: 2018 VS 2022 VS 2029
1.6.2 Global Saliva-based Screening Market Size by Region, (2018-2029)
1.6.3 North America Saliva-based Screening Market Size and Prospect (2018-2029)
1.6.4 Europe Saliva-based Screening Market Size and Prospect (2018-2029)
1.6.5 Asia-Pacific Saliva-based Screening Market Size and Prospect (2018-2029)
1.6.6 South America Saliva-based Screening Market Size and Prospect (2018-2029)
1.6.7 Middle East and Africa Saliva-based Screening Market Size and Prospect (2018-2029)
2 Company Profiles
2.1 Thermo Fisher scientific
2.1.1 Thermo Fisher scientific Details
2.1.2 Thermo Fisher scientific Major Business
2.1.3 Thermo Fisher scientific Saliva-based Screening Product and Solutions
2.1.4 Thermo Fisher scientific Saliva-based Screening Revenue, Gross Margin and Market Share (2018-2023)
2.1.5 Thermo Fisher scientific Recent Developments and Future Plans
2.2 Qiagen
2.2.1 Qiagen Details
2.2.2 Qiagen Major Business
2.2.3 Qiagen Saliva-based Screening Product and Solutions
2.2.4 Qiagen Saliva-based Screening Revenue, Gross Margin and Market Share (2018-2023)
2.2.5 Qiagen Recent Developments and Future Plans
2.3 Hologic
2.3.1 Hologic Details
2.3.2 Hologic Major Business
2.3.3 Hologic Saliva-based Screening Product and Solutions
2.3.4 Hologic Saliva-based Screening Revenue, Gross Margin and Market Share (2018-2023)
2.3.5 Hologic Recent Developments and Future Plans
2.4 Takara Bio Inc
2.4.1 Takara Bio Inc Details
2.4.2 Takara Bio Inc Major Business
2.4.3 Takara Bio Inc Saliva-based Screening Product and Solutions
2.4.4 Takara Bio Inc Saliva-based Screening Revenue, Gross Margin and Market Share (2018-2023)
2.4.5 Takara Bio Inc Recent Developments and Future Plans
2.5 Arcis Biotechnology Limited
2.5.1 Arcis Biotechnology Limited Details
2.5.2 Arcis Biotechnology Limited Major Business
2.5.3 Arcis Biotechnology Limited Saliva-based Screening Product and Solutions
2.5.4 Arcis Biotechnology Limited Saliva-based Screening Revenue, Gross Margin and Market Share (2018-2023)
2.5.5 Arcis Biotechnology Limited Recent Developments and Future Plans
2.6 GeneProof
2.6.1 GeneProof Details
2.6.2 GeneProof Major Business
2.6.3 GeneProof Saliva-based Screening Product and Solutions
2.6.4 GeneProof Saliva-based Screening Revenue, Gross Margin and Market Share (2018-2023)
2.6.5 GeneProof Recent Developments and Future Plans
2.7 Abacus ALS
2.7.1 Abacus ALS Details
2.7.2 Abacus ALS Major Business
2.7.3 Abacus ALS Saliva-based Screening Product and Solutions
2.7.4 Abacus ALS Saliva-based Screening Revenue, Gross Margin and Market Share (2018-2023)
2.7.5 Abacus ALS Recent Developments and Future Plans
2.8 Chai Inc.
2.8.1 Chai Inc. Details
2.8.2 Chai Inc. Major Business
2.8.3 Chai Inc. Saliva-based Screening Product and Solutions
2.8.4 Chai Inc. Saliva-based Screening Revenue, Gross Margin and Market Share (2018-2023)
2.8.5 Chai Inc. Recent Developments and Future Plans
2.9 Kolplast Group
2.9.1 Kolplast Group Details
2.9.2 Kolplast Group Major Business
2.9.3 Kolplast Group Saliva-based Screening Product and Solutions
2.9.4 Kolplast Group Saliva-based Screening Revenue, Gross Margin and Market Share (2018-2023)
2.9.5 Kolplast Group Recent Developments and Future Plans
2.10 Lucence Health INc
2.10.1 Lucence Health INc Details
2.10.2 Lucence Health INc Major Business
2.10.3 Lucence Health INc Saliva-based Screening Product and Solutions
2.10.4 Lucence Health INc Saliva-based Screening Revenue, Gross Margin and Market Share (2018-2023)
2.10.5 Lucence Health INc Recent Developments and Future Plans
2.11 Vitagene
2.11.1 Vitagene Details
2.11.2 Vitagene Major Business
2.11.3 Vitagene Saliva-based Screening Product and Solutions
2.11.4 Vitagene Saliva-based Screening Revenue, Gross Margin and Market Share (2018-2023)
2.11.5 Vitagene Recent Developments and Future Plans
2.12 Therma Bright Inc
2.12.1 Therma Bright Inc Details
2.12.2 Therma Bright Inc Major Business
2.12.3 Therma Bright Inc Saliva-based Screening Product and Solutions
2.12.4 Therma Bright Inc Saliva-based Screening Revenue, Gross Margin and Market Share (2018-2023)
2.12.5 Therma Bright Inc Recent Developments and Future Plans
2.13 ACON Laboratories, Inc
2.13.1 ACON Laboratories, Inc Details
2.13.2 ACON Laboratories, Inc Major Business
2.13.3 ACON Laboratories, Inc Saliva-based Screening Product and Solutions
2.13.4 ACON Laboratories, Inc Saliva-based Screening Revenue, Gross Margin and Market Share (2018-2023)
2.13.5 ACON Laboratories, Inc Recent Developments and Future Plans
2.14 TODA PHARMA
2.14.1 TODA PHARMA Details
2.14.2 TODA PHARMA Major Business
2.14.3 TODA PHARMA Saliva-based Screening Product and Solutions
2.14.4 TODA PHARMA Saliva-based Screening Revenue, Gross Margin and Market Share (2018-2023)
2.14.5 TODA PHARMA Recent Developments and Future Plans
2.15 Norgen Biotek Corp.
2.15.1 Norgen Biotek Corp. Details
2.15.2 Norgen Biotek Corp. Major Business
2.15.3 Norgen Biotek Corp. Saliva-based Screening Product and Solutions
2.15.4 Norgen Biotek Corp. Saliva-based Screening Revenue, Gross Margin and Market Share (2018-2023)
2.15.5 Norgen Biotek Corp. Recent Developments and Future Plans
2.16 Assure Tech. (Hangzhou) Co., Ltd
2.16.1 Assure Tech. (Hangzhou) Co., Ltd Details
2.16.2 Assure Tech. (Hangzhou) Co., Ltd Major Business
2.16.3 Assure Tech. (Hangzhou) Co., Ltd Saliva-based Screening Product and Solutions
2.16.4 Assure Tech. (Hangzhou) Co., Ltd Saliva-based Screening Revenue, Gross Margin and Market Share (2018-2023)
2.16.5 Assure Tech. (Hangzhou) Co., Ltd Recent Developments and Future Plans
2.17 Beijing Hotgen Biotech Co., Ltd
2.17.1 Beijing Hotgen Biotech Co., Ltd Details
2.17.2 Beijing Hotgen Biotech Co., Ltd Major Business
2.17.3 Beijing Hotgen Biotech Co., Ltd Saliva-based Screening Product and Solutions
2.17.4 Beijing Hotgen Biotech Co., Ltd Saliva-based Screening Revenue, Gross Margin and Market Share (2018-2023)
2.17.5 Beijing Hotgen Biotech Co., Ltd Recent Developments and Future Plans
2.18 Nantong Diagnos Biotechnology Co., Ltd
2.18.1 Nantong Diagnos Biotechnology Co., Ltd Details
2.18.2 Nantong Diagnos Biotechnology Co., Ltd Major Business
2.18.3 Nantong Diagnos Biotechnology Co., Ltd Saliva-based Screening Product and Solutions
2.18.4 Nantong Diagnos Biotechnology Co., Ltd Saliva-based Screening Revenue, Gross Margin and Market Share (2018-2023)
2.18.5 Nantong Diagnos Biotechnology Co., Ltd Recent Developments and Future Plans
2.19 NeuMoDx Molecular, Inc.
2.19.1 NeuMoDx Molecular, Inc. Details
2.19.2 NeuMoDx Molecular, Inc. Major Business
2.19.3 NeuMoDx Molecular, Inc. Saliva-based Screening Product and Solutions
2.19.4 NeuMoDx Molecular, Inc. Saliva-based Screening Revenue, Gross Margin and Market Share (2018-2023)
2.19.5 NeuMoDx Molecular, Inc. Recent Developments and Future Plans
2.20 KYODO INTERNATIONAL INC.
2.20.1 KYODO INTERNATIONAL INC. Details
2.20.2 KYODO INTERNATIONAL INC. Major Business
2.20.3 KYODO INTERNATIONAL INC. Saliva-based Screening Product and Solutions
2.20.4 KYODO INTERNATIONAL INC. Saliva-based Screening Revenue, Gross Margin and Market Share (2018-2023)
2.20.5 KYODO INTERNATIONAL INC. Recent Developments and Future Plans
2.21 Canvax
2.21.1 Canvax Details
2.21.2 Canvax Major Business
2.21.3 Canvax Saliva-based Screening Product and Solutions
2.21.4 Canvax Saliva-based Screening Revenue, Gross Margin and Market Share (2018-2023)
2.21.5 Canvax Recent Developments and Future Plans
2.22 Zymo Research Corporation.
2.22.1 Zymo Research Corporation. Details
2.22.2 Zymo Research Corporation. Major Business
2.22.3 Zymo Research Corporation. Saliva-based Screening Product and Solutions
2.22.4 Zymo Research Corporation. Saliva-based Screening Revenue, Gross Margin and Market Share (2018-2023)
2.22.5 Zymo Research Corporation. Recent Developments and Future Plans
2.23 Salimetrics
2.23.1 Salimetrics Details
2.23.2 Salimetrics Major Business
2.23.3 Salimetrics Saliva-based Screening Product and Solutions
2.23.4 Salimetrics Saliva-based Screening Revenue, Gross Margin and Market Share (2018-2023)
2.23.5 Salimetrics Recent Developments and Future Plans
2.24 NEST Scientific USA
2.24.1 NEST Scientific USA Details
2.24.2 NEST Scientific USA Major Business
2.24.3 NEST Scientific USA Saliva-based Screening Product and Solutions
2.24.4 NEST Scientific USA Saliva-based Screening Revenue, Gross Margin and Market Share (2018-2023)
2.24.5 NEST Scientific USA Recent Developments and Future Plans
2.25 Miraclean Technology Co. Ltd
2.25.1 Miraclean Technology Co. Ltd Details
2.25.2 Miraclean Technology Co. Ltd Major Business
2.25.3 Miraclean Technology Co. Ltd Saliva-based Screening Product and Solutions
2.25.4 Miraclean Technology Co. Ltd Saliva-based Screening Revenue, Gross Margin and Market Share (2018-2023)
2.25.5 Miraclean Technology Co. Ltd Recent Developments and Future Plans
2.26 Mawi DNA Technologies
2.26.1 Mawi DNA Technologies Details
2.26.2 Mawi DNA Technologies Major Business
2.26.3 Mawi DNA Technologies Saliva-based Screening Product and Solutions
2.26.4 Mawi DNA Technologies Saliva-based Screening Revenue, Gross Margin and Market Share (2018-2023)
2.26.5 Mawi DNA Technologies Recent Developments and Future Plans
2.27 Cell Projects Ltd.
2.27.1 Cell Projects Ltd. Details
2.27.2 Cell Projects Ltd. Major Business
2.27.3 Cell Projects Ltd. Saliva-based Screening Product and Solutions
2.27.4 Cell Projects Ltd. Saliva-based Screening Revenue, Gross Margin and Market Share (2018-2023)
2.27.5 Cell Projects Ltd. Recent Developments and Future Plans
3 Market Competition, by Players
3.1 Global Saliva-based Screening Revenue and Share by Players (2018-2023)
3.2 Market Share Analysis (2022)
3.2.1 Market Share of Saliva-based Screening by Company Revenue
3.2.2 Top 3 Saliva-based Screening Players Market Share in 2022
3.2.3 Top 6 Saliva-based Screening Players Market Share in 2022
3.3 Saliva-based Screening Market: Overall Company Footprint Analysis
3.3.1 Saliva-based Screening Market: Region Footprint
3.3.2 Saliva-based Screening Market: Company Product Type Footprint
3.3.3 Saliva-based Screening Market: Company Product Application Footprint
3.4 New Market Entrants and Barriers to Market Entry
3.5 Mergers, Acquisition, Agreements, and Collaborations
4 Market Size Segment by Type
4.1 Global Saliva-based Screening Consumption Value and Market Share by Type (2018-2023)
4.2 Global Saliva-based Screening Market Forecast by Type (2024-2029)
5 Market Size Segment by Application
5.1 Global Saliva-based Screening Consumption Value Market Share by Application (2018-2023)
5.2 Global Saliva-based Screening Market Forecast by Application (2024-2029)
6 North America
6.1 North America Saliva-based Screening Consumption Value by Type (2018-2029)
6.2 North America Saliva-based Screening Consumption Value by Application (2018-2029)
6.3 North America Saliva-based Screening Market Size by Country
6.3.1 North America Saliva-based Screening Consumption Value by Country (2018-2029)
6.3.2 United States Saliva-based Screening Market Size and Forecast (2018-2029)
6.3.3 Canada Saliva-based Screening Market Size and Forecast (2018-2029)
6.3.4 Mexico Saliva-based Screening Market Size and Forecast (2018-2029)
7 Europe
7.1 Europe Saliva-based Screening Consumption Value by Type (2018-2029)
7.2 Europe Saliva-based Screening Consumption Value by Application (2018-2029)
7.3 Europe Saliva-based Screening Market Size by Country
7.3.1 Europe Saliva-based Screening Consumption Value by Country (2018-2029)
7.3.2 Germany Saliva-based Screening Market Size and Forecast (2018-2029)
7.3.3 France Saliva-based Screening Market Size and Forecast (2018-2029)
7.3.4 United Kingdom Saliva-based Screening Market Size and Forecast (2018-2029)
7.3.5 Russia Saliva-based Screening Market Size and Forecast (2018-2029)
7.3.6 Italy Saliva-based Screening Market Size and Forecast (2018-2029)
8 Asia-Pacific
8.1 Asia-Pacific Saliva-based Screening Consumption Value by Type (2018-2029)
8.2 Asia-Pacific Saliva-based Screening Consumption Value by Application (2018-2029)
8.3 Asia-Pacific Saliva-based Screening Market Size by Region
8.3.1 Asia-Pacific Saliva-based Screening Consumption Value by Region (2018-2029)
8.3.2 China Saliva-based Screening Market Size and Forecast (2018-2029)
8.3.3 Japan Saliva-based Screening Market Size and Forecast (2018-2029)
8.3.4 South Korea Saliva-based Screening Market Size and Forecast (2018-2029)
8.3.5 India Saliva-based Screening Market Size and Forecast (2018-2029)
8.3.6 Southeast Asia Saliva-based Screening Market Size and Forecast (2018-2029)
8.3.7 Australia Saliva-based Screening Market Size and Forecast (2018-2029)
9 South America
9.1 South America Saliva-based Screening Consumption Value by Type (2018-2029)
9.2 South America Saliva-based Screening Consumption Value by Application (2018-2029)
9.3 South America Saliva-based Screening Market Size by Country
9.3.1 South America Saliva-based Screening Consumption Value by Country (2018-2029)
9.3.2 Brazil Saliva-based Screening Market Size and Forecast (2018-2029)
9.3.3 Argentina Saliva-based Screening Market Size and Forecast (2018-2029)
10 Middle East & Africa
10.1 Middle East & Africa Saliva-based Screening Consumption Value by Type (2018-2029)
10.2 Middle East & Africa Saliva-based Screening Consumption Value by Application (2018-2029)
10.3 Middle East & Africa Saliva-based Screening Market Size by Country
10.3.1 Middle East & Africa Saliva-based Screening Consumption Value by Country (2018-2029)
10.3.2 Turkey Saliva-based Screening Market Size and Forecast (2018-2029)
10.3.3 Saudi Arabia Saliva-based Screening Market Size and Forecast (2018-2029)
10.3.4 UAE Saliva-based Screening Market Size and Forecast (2018-2029)
11 Market Dynamics
11.1 Saliva-based Screening Market Drivers
11.2 Saliva-based Screening Market Restraints
11.3 Saliva-based Screening Trends Analysis
11.4 Porters Five Forces Analysis
11.4.1 Threat of New Entrants
11.4.2 Bargaining Power of Suppliers
11.4.3 Bargaining Power of Buyers
11.4.4 Threat of Substitutes
11.4.5 Competitive Rivalry
11.5 Influence of COVID-19 and Russia-Ukraine War
11.5.1 Influence of COVID-19
11.5.2 Influence of Russia-Ukraine War
12 Industry Chain Analysis
12.1 Saliva-based Screening Industry Chain
12.2 Saliva-based Screening Upstream Analysis
12.3 Saliva-based Screening Midstream Analysis
12.4 Saliva-based Screening Downstream Analysis
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
List of Tables
Table 1. Global Saliva-based Screening Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Table 2. Global Saliva-based Screening Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Table 3. Global Saliva-based Screening Consumption Value by Region (2018-2023) & (USD Million)
Table 4. Global Saliva-based Screening Consumption Value by Region (2024-2029) & (USD Million)
Table 5. Thermo Fisher scientific Company Information, Head Office, and Major Competitors
Table 6. Thermo Fisher scientific Major Business
Table 7. Thermo Fisher scientific Saliva-based Screening Product and Solutions
Table 8. Thermo Fisher scientific Saliva-based Screening Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 9. Thermo Fisher scientific Recent Developments and Future Plans
Table 10. Qiagen Company Information, Head Office, and Major Competitors
Table 11. Qiagen Major Business
Table 12. Qiagen Saliva-based Screening Product and Solutions
Table 13. Qiagen Saliva-based Screening Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 14. Qiagen Recent Developments and Future Plans
Table 15. Hologic Company Information, Head Office, and Major Competitors
Table 16. Hologic Major Business
Table 17. Hologic Saliva-based Screening Product and Solutions
Table 18. Hologic Saliva-based Screening Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 19. Hologic Recent Developments and Future Plans
Table 20. Takara Bio Inc Company Information, Head Office, and Major Competitors
Table 21. Takara Bio Inc Major Business
Table 22. Takara Bio Inc Saliva-based Screening Product and Solutions
Table 23. Takara Bio Inc Saliva-based Screening Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 24. Takara Bio Inc Recent Developments and Future Plans
Table 25. Arcis Biotechnology Limited Company Information, Head Office, and Major Competitors
Table 26. Arcis Biotechnology Limited Major Business
Table 27. Arcis Biotechnology Limited Saliva-based Screening Product and Solutions
Table 28. Arcis Biotechnology Limited Saliva-based Screening Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 29. Arcis Biotechnology Limited Recent Developments and Future Plans
Table 30. GeneProof Company Information, Head Office, and Major Competitors
Table 31. GeneProof Major Business
Table 32. GeneProof Saliva-based Screening Product and Solutions
Table 33. GeneProof Saliva-based Screening Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 34. GeneProof Recent Developments and Future Plans
Table 35. Abacus ALS Company Information, Head Office, and Major Competitors
Table 36. Abacus ALS Major Business
Table 37. Abacus ALS Saliva-based Screening Product and Solutions
Table 38. Abacus ALS Saliva-based Screening Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 39. Abacus ALS Recent Developments and Future Plans
Table 40. Chai Inc. Company Information, Head Office, and Major Competitors
Table 41. Chai Inc. Major Business
Table 42. Chai Inc. Saliva-based Screening Product and Solutions
Table 43. Chai Inc. Saliva-based Screening Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 44. Chai Inc. Recent Developments and Future Plans
Table 45. Kolplast Group Company Information, Head Office, and Major Competitors
Table 46. Kolplast Group Major Business
Table 47. Kolplast Group Saliva-based Screening Product and Solutions
Table 48. Kolplast Group Saliva-based Screening Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 49. Kolplast Group Recent Developments and Future Plans
Table 50. Lucence Health INc Company Information, Head Office, and Major Competitors
Table 51. Lucence Health INc Major Business
Table 52. Lucence Health INc Saliva-based Screening Product and Solutions
Table 53. Lucence Health INc Saliva-based Screening Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 54. Lucence Health INc Recent Developments and Future Plans
Table 55. Vitagene Company Information, Head Office, and Major Competitors
Table 56. Vitagene Major Business
Table 57. Vitagene Saliva-based Screening Product and Solutions
Table 58. Vitagene Saliva-based Screening Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 59. Vitagene Recent Developments and Future Plans
Table 60. Therma Bright Inc Company Information, Head Office, and Major Competitors
Table 61. Therma Bright Inc Major Business
Table 62. Therma Bright Inc Saliva-based Screening Product and Solutions
Table 63. Therma Bright Inc Saliva-based Screening Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 64. Therma Bright Inc Recent Developments and Future Plans
Table 65. ACON Laboratories, Inc Company Information, Head Office, and Major Competitors
Table 66. ACON Laboratories, Inc Major Business
Table 67. ACON Laboratories, Inc Saliva-based Screening Product and Solutions
Table 68. ACON Laboratories, Inc Saliva-based Screening Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 69. ACON Laboratories, Inc Recent Developments and Future Plans
Table 70. TODA PHARMA Company Information, Head Office, and Major Competitors
Table 71. TODA PHARMA Major Business
Table 72. TODA PHARMA Saliva-based Screening Product and Solutions
Table 73. TODA PHARMA Saliva-based Screening Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 74. TODA PHARMA Recent Developments and Future Plans
Table 75. Norgen Biotek Corp. Company Information, Head Office, and Major Competitors
Table 76. Norgen Biotek Corp. Major Business
Table 77. Norgen Biotek Corp. Saliva-based Screening Product and Solutions
Table 78. Norgen Biotek Corp. Saliva-based Screening Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 79. Norgen Biotek Corp. Recent Developments and Future Plans
Table 80. Assure Tech. (Hangzhou) Co., Ltd Company Information, Head Office, and Major Competitors
Table 81. Assure Tech. (Hangzhou) Co., Ltd Major Business
Table 82. Assure Tech. (Hangzhou) Co., Ltd Saliva-based Screening Product and Solutions
Table 83. Assure Tech. (Hangzhou) Co., Ltd Saliva-based Screening Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 84. Assure Tech. (Hangzhou) Co., Ltd Recent Developments and Future Plans
Table 85. Beijing Hotgen Biotech Co., Ltd Company Information, Head Office, and Major Competitors
Table 86. Beijing Hotgen Biotech Co., Ltd Major Business
Table 87. Beijing Hotgen Biotech Co., Ltd Saliva-based Screening Product and Solutions
Table 88. Beijing Hotgen Biotech Co., Ltd Saliva-based Screening Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 89. Beijing Hotgen Biotech Co., Ltd Recent Developments and Future Plans
Table 90. Nantong Diagnos Biotechnology Co., Ltd Company Information, Head Office, and Major Competitors
Table 91. Nantong Diagnos Biotechnology Co., Ltd Major Business
Table 92. Nantong Diagnos Biotechnology Co., Ltd Saliva-based Screening Product and Solutions
Table 93. Nantong Diagnos Biotechnology Co., Ltd Saliva-based Screening Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 94. Nantong Diagnos Biotechnology Co., Ltd Recent Developments and Future Plans
Table 95. NeuMoDx Molecular, Inc. Company Information, Head Office, and Major Competitors
Table 96. NeuMoDx Molecular, Inc. Major Business
Table 97. NeuMoDx Molecular, Inc. Saliva-based Screening Product and Solutions
Table 98. NeuMoDx Molecular, Inc. Saliva-based Screening Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 99. NeuMoDx Molecular, Inc. Recent Developments and Future Plans
Table 100. KYODO INTERNATIONAL INC. Company Information, Head Office, and Major Competitors
Table 101. KYODO INTERNATIONAL INC. Major Business
Table 102. KYODO INTERNATIONAL INC. Saliva-based Screening Product and Solutions
Table 103. KYODO INTERNATIONAL INC. Saliva-based Screening Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 104. KYODO INTERNATIONAL INC. Recent Developments and Future Plans
Table 105. Canvax Company Information, Head Office, and Major Competitors
Table 106. Canvax Major Business
Table 107. Canvax Saliva-based Screening Product and Solutions
Table 108. Canvax Saliva-based Screening Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 109. Canvax Recent Developments and Future Plans
Table 110. Zymo Research Corporation. Company Information, Head Office, and Major Competitors
Table 111. Zymo Research Corporation. Major Business
Table 112. Zymo Research Corporation. Saliva-based Screening Product and Solutions
Table 113. Zymo Research Corporation. Saliva-based Screening Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 114. Zymo Research Corporation. Recent Developments and Future Plans
Table 115. Salimetrics Company Information, Head Office, and Major Competitors
Table 116. Salimetrics Major Business
Table 117. Salimetrics Saliva-based Screening Product and Solutions
Table 118. Salimetrics Saliva-based Screening Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 119. Salimetrics Recent Developments and Future Plans
Table 120. NEST Scientific USA Company Information, Head Office, and Major Competitors
Table 121. NEST Scientific USA Major Business
Table 122. NEST Scientific USA Saliva-based Screening Product and Solutions
Table 123. NEST Scientific USA Saliva-based Screening Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 124. NEST Scientific USA Recent Developments and Future Plans
Table 125. Miraclean Technology Co. Ltd Company Information, Head Office, and Major Competitors
Table 126. Miraclean Technology Co. Ltd Major Business
Table 127. Miraclean Technology Co. Ltd Saliva-based Screening Product and Solutions
Table 128. Miraclean Technology Co. Ltd Saliva-based Screening Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 129. Miraclean Technology Co. Ltd Recent Developments and Future Plans
Table 130. Mawi DNA Technologies Company Information, Head Office, and Major Competitors
Table 131. Mawi DNA Technologies Major Business
Table 132. Mawi DNA Technologies Saliva-based Screening Product and Solutions
Table 133. Mawi DNA Technologies Saliva-based Screening Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 134. Mawi DNA Technologies Recent Developments and Future Plans
Table 135. Cell Projects Ltd. Company Information, Head Office, and Major Competitors
Table 136. Cell Projects Ltd. Major Business
Table 137. Cell Projects Ltd. Saliva-based Screening Product and Solutions
Table 138. Cell Projects Ltd. Saliva-based Screening Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 139. Cell Projects Ltd. Recent Developments and Future Plans
Table 140. Global Saliva-based Screening Revenue (USD Million) by Players (2018-2023)
Table 141. Global Saliva-based Screening Revenue Share by Players (2018-2023)
Table 142. Breakdown of Saliva-based Screening by Company Type (Tier 1, Tier 2, and Tier 3)
Table 143. Market Position of Players in Saliva-based Screening, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2022
Table 144. Head Office of Key Saliva-based Screening Players
Table 145. Saliva-based Screening Market: Company Product Type Footprint
Table 146. Saliva-based Screening Market: Company Product Application Footprint
Table 147. Saliva-based Screening New Market Entrants and Barriers to Market Entry
Table 148. Saliva-based Screening Mergers, Acquisition, Agreements, and Collaborations
Table 149. Global Saliva-based Screening Consumption Value (USD Million) by Type (2018-2023)
Table 150. Global Saliva-based Screening Consumption Value Share by Type (2018-2023)
Table 151. Global Saliva-based Screening Consumption Value Forecast by Type (2024-2029)
Table 152. Global Saliva-based Screening Consumption Value by Application (2018-2023)
Table 153. Global Saliva-based Screening Consumption Value Forecast by Application (2024-2029)
Table 154. North America Saliva-based Screening Consumption Value by Type (2018-2023) & (USD Million)
Table 155. North America Saliva-based Screening Consumption Value by Type (2024-2029) & (USD Million)
Table 156. North America Saliva-based Screening Consumption Value by Application (2018-2023) & (USD Million)
Table 157. North America Saliva-based Screening Consumption Value by Application (2024-2029) & (USD Million)
Table 158. North America Saliva-based Screening Consumption Value by Country (2018-2023) & (USD Million)
Table 159. North America Saliva-based Screening Consumption Value by Country (2024-2029) & (USD Million)
Table 160. Europe Saliva-based Screening Consumption Value by Type (2018-2023) & (USD Million)
Table 161. Europe Saliva-based Screening Consumption Value by Type (2024-2029) & (USD Million)
Table 162. Europe Saliva-based Screening Consumption Value by Application (2018-2023) & (USD Million)
Table 163. Europe Saliva-based Screening Consumption Value by Application (2024-2029) & (USD Million)
Table 164. Europe Saliva-based Screening Consumption Value by Country (2018-2023) & (USD Million)
Table 165. Europe Saliva-based Screening Consumption Value by Country (2024-2029) & (USD Million)
Table 166. Asia-Pacific Saliva-based Screening Consumption Value by Type (2018-2023) & (USD Million)
Table 167. Asia-Pacific Saliva-based Screening Consumption Value by Type (2024-2029) & (USD Million)
Table 168. Asia-Pacific Saliva-based Screening Consumption Value by Application (2018-2023) & (USD Million)
Table 169. Asia-Pacific Saliva-based Screening Consumption Value by Application (2024-2029) & (USD Million)
Table 170. Asia-Pacific Saliva-based Screening Consumption Value by Region (2018-2023) & (USD Million)
Table 171. Asia-Pacific Saliva-based Screening Consumption Value by Region (2024-2029) & (USD Million)
Table 172. South America Saliva-based Screening Consumption Value by Type (2018-2023) & (USD Million)
Table 173. South America Saliva-based Screening Consumption Value by Type (2024-2029) & (USD Million)
Table 174. South America Saliva-based Screening Consumption Value by Application (2018-2023) & (USD Million)
Table 175. South America Saliva-based Screening Consumption Value by Application (2024-2029) & (USD Million)
Table 176. South America Saliva-based Screening Consumption Value by Country (2018-2023) & (USD Million)
Table 177. South America Saliva-based Screening Consumption Value by Country (2024-2029) & (USD Million)
Table 178. Middle East & Africa Saliva-based Screening Consumption Value by Type (2018-2023) & (USD Million)
Table 179. Middle East & Africa Saliva-based Screening Consumption Value by Type (2024-2029) & (USD Million)
Table 180. Middle East & Africa Saliva-based Screening Consumption Value by Application (2018-2023) & (USD Million)
Table 181. Middle East & Africa Saliva-based Screening Consumption Value by Application (2024-2029) & (USD Million)
Table 182. Middle East & Africa Saliva-based Screening Consumption Value by Country (2018-2023) & (USD Million)
Table 183. Middle East & Africa Saliva-based Screening Consumption Value by Country (2024-2029) & (USD Million)
Table 184. Saliva-based Screening Raw Material
Table 185. Key Suppliers of Saliva-based Screening Raw Materials
List of Figures
Figure 1. Saliva-based Screening Picture
Figure 2. Global Saliva-based Screening Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 3. Global Saliva-based Screening Consumption Value Market Share by Type in 2022
Figure 4. Direct Sample to PCR
Figure 5. RT-qPCR
Figure 6. Lateral Flow Assays
Figure 7. Global Saliva-based Screening Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 8. Saliva-based Screening Consumption Value Market Share by Application in 2022
Figure 9. Diagnostic Laboratories Picture
Figure 10. Hospitals & Clinics Picture
Figure 11. Others Picture
Figure 12. Global Saliva-based Screening Consumption Value, (USD Million): 2018 & 2022 & 2029
Figure 13. Global Saliva-based Screening Consumption Value and Forecast (2018-2029) & (USD Million)
Figure 14. Global Market Saliva-based Screening Consumption Value (USD Million) Comparison by Region (2018 & 2022 & 2029)
Figure 15. Global Saliva-based Screening Consumption Value Market Share by Region (2018-2029)
Figure 16. Global Saliva-based Screening Consumption Value Market Share by Region in 2022
Figure 17. North America Saliva-based Screening Consumption Value (2018-2029) & (USD Million)
Figure 18. Europe Saliva-based Screening Consumption Value (2018-2029) & (USD Million)
Figure 19. Asia-Pacific Saliva-based Screening Consumption Value (2018-2029) & (USD Million)
Figure 20. South America Saliva-based Screening Consumption Value (2018-2029) & (USD Million)
Figure 21. Middle East and Africa Saliva-based Screening Consumption Value (2018-2029) & (USD Million)
Figure 22. Global Saliva-based Screening Revenue Share by Players in 2022
Figure 23. Saliva-based Screening Market Share by Company Type (Tier 1, Tier 2 and Tier 3) in 2022
Figure 24. Global Top 3 Players Saliva-based Screening Market Share in 2022
Figure 25. Global Top 6 Players Saliva-based Screening Market Share in 2022
Figure 26. Global Saliva-based Screening Consumption Value Share by Type (2018-2023)
Figure 27. Global Saliva-based Screening Market Share Forecast by Type (2024-2029)
Figure 28. Global Saliva-based Screening Consumption Value Share by Application (2018-2023)
Figure 29. Global Saliva-based Screening Market Share Forecast by Application (2024-2029)
Figure 30. North America Saliva-based Screening Consumption Value Market Share by Type (2018-2029)
Figure 31. North America Saliva-based Screening Consumption Value Market Share by Application (2018-2029)
Figure 32. North America Saliva-based Screening Consumption Value Market Share by Country (2018-2029)
Figure 33. United States Saliva-based Screening Consumption Value (2018-2029) & (USD Million)
Figure 34. Canada Saliva-based Screening Consumption Value (2018-2029) & (USD Million)
Figure 35. Mexico Saliva-based Screening Consumption Value (2018-2029) & (USD Million)
Figure 36. Europe Saliva-based Screening Consumption Value Market Share by Type (2018-2029)
Figure 37. Europe Saliva-based Screening Consumption Value Market Share by Application (2018-2029)
Figure 38. Europe Saliva-based Screening Consumption Value Market Share by Country (2018-2029)
Figure 39. Germany Saliva-based Screening Consumption Value (2018-2029) & (USD Million)
Figure 40. France Saliva-based Screening Consumption Value (2018-2029) & (USD Million)
Figure 41. United Kingdom Saliva-based Screening Consumption Value (2018-2029) & (USD Million)
Figure 42. Russia Saliva-based Screening Consumption Value (2018-2029) & (USD Million)
Figure 43. Italy Saliva-based Screening Consumption Value (2018-2029) & (USD Million)
Figure 44. Asia-Pacific Saliva-based Screening Consumption Value Market Share by Type (2018-2029)
Figure 45. Asia-Pacific Saliva-based Screening Consumption Value Market Share by Application (2018-2029)
Figure 46. Asia-Pacific Saliva-based Screening Consumption Value Market Share by Region (2018-2029)
Figure 47. China Saliva-based Screening Consumption Value (2018-2029) & (USD Million)
Figure 48. Japan Saliva-based Screening Consumption Value (2018-2029) & (USD Million)
Figure 49. South Korea Saliva-based Screening Consumption Value (2018-2029) & (USD Million)
Figure 50. India Saliva-based Screening Consumption Value (2018-2029) & (USD Million)
Figure 51. Southeast Asia Saliva-based Screening Consumption Value (2018-2029) & (USD Million)
Figure 52. Australia Saliva-based Screening Consumption Value (2018-2029) & (USD Million)
Figure 53. South America Saliva-based Screening Consumption Value Market Share by Type (2018-2029)
Figure 54. South America Saliva-based Screening Consumption Value Market Share by Application (2018-2029)
Figure 55. South America Saliva-based Screening Consumption Value Market Share by Country (2018-2029)
Figure 56. Brazil Saliva-based Screening Consumption Value (2018-2029) & (USD Million)
Figure 57. Argentina Saliva-based Screening Consumption Value (2018-2029) & (USD Million)
Figure 58. Middle East and Africa Saliva-based Screening Consumption Value Market Share by Type (2018-2029)
Figure 59. Middle East and Africa Saliva-based Screening Consumption Value Market Share by Application (2018-2029)
Figure 60. Middle East and Africa Saliva-based Screening Consumption Value Market Share by Country (2018-2029)
Figure 61. Turkey Saliva-based Screening Consumption Value (2018-2029) & (USD Million)
Figure 62. Saudi Arabia Saliva-based Screening Consumption Value (2018-2029) & (USD Million)
Figure 63. UAE Saliva-based Screening Consumption Value (2018-2029) & (USD Million)
Figure 64. Saliva-based Screening Market Drivers
Figure 65. Saliva-based Screening Market Restraints
Figure 66. Saliva-based Screening Market Trends
Figure 67. Porters Five Forces Analysis
Figure 68. Manufacturing Cost Structure Analysis of Saliva-based Screening in 2022
Figure 69. Manufacturing Process Analysis of Saliva-based Screening
Figure 70. Saliva-based Screening Industrial Chain
Figure 71. Methodology
Figure 72. Research Process and Data Source
Please feel free to write an email to us or to use our electronic ticketing system.
